Jiangsu Yuyue Medical Equipment & Supply Co Ltd

Chart & Performance

D1W1MN

P/E

14.86

P/S

4.47

EPS

2.40

Div Yield, %

1.68%

Shrs. gr., 5y

0.12%

Rev. gr., 5y

13.76%

Revenues

7.97b

+12.25%

Net income

2.40b

+50.21%

CFO

2.13b

-7.72%

Dividend

Oct 10, 20240.4 CNY/sh

Profile

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. engages in the manufacture and sale of medical devices in China and internationally. The company offers respiratory therapy solutions, including ventilator, humidifier, oxygen generator, and atomizer, as well as non-invasive ventilator data management system; chronic disease monitoring systems, such as sphygmomanometer, blood glucose meter, blood oxygen monitoring, blood temperature detection, stethoscope, as well as general practice diagnostic and in-hospital blood glucose management platform. It also provides imaging diagnosis and treatment solutions, which include ultrasound diagnostic imaging, and intervention and minimally invasive solutions; infection control and disinfection products; and ophthalmology and vision care products comprising microscope, eye surgery instrument, ophthalmoscope, synoptograph, and keratometer; and defibrillator monitors. In addition, the company offers durable equipment and consumables consisting of basic surgery, microsurgery, five sense organs, orthopedic tools and equipment, endoscopic, kiss combiner, dental appliance, acupuncture, electronic acupuncture, absorbable suture, and venous indwelling needle puncture products. The company was formerly known as Yuwell medical. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. was founded in 1998 and is headquartered in Shanghai, China.

URL

https://www.yuwell.com/

IPO date

Apr 18, 2008

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	7,971,734 12.25%	7,101,679 3.01%	6,894,308 2.51%
Cost of revenue	5,216,318	5,323,449	5,068,662
Unusual Expense (Income)
NOPBT	2,755,416	1,778,231	1,825,646
NOPBT Margin	34.56%	25.04%	26.48%
Operating Taxes	472,362	269,728	217,820
Tax Rate	17.14%	15.17%	11.93%
NOPAT	2,283,054	1,508,503	1,607,826
Net income	2,395,853 50.21%	1,595,037 7.60%	1,482,422 -15.73%
Dividends	(597,748)	(298,874)	(297,038)
Dividend yield	1.73%	0.95%	0.79%
Proceeds from repurchase of equity			(200,980)
BB yield			0.53%
Debt
Debt current	25,601	573,962	41,242
Long-term debt	741,276	1,570,847	1,491,938
Deferred revenue	227,307	242,552	193,169
Other long-term liabilities	16,046	13,854	15,598
Net debt	(9,035,287)	(5,207,873)	(3,141,626)
Cash flow
Cash from operating activities	2,126,978	2,304,919	1,201,202
CAPEX	(132,574)
Cash from investing activities	1,735,269
Cash from financing activities	(1,468,159)	354,895	774,705
FCF	2,315,972	1,742,333	1,319,054
Balance
Cash	7,215,419	7,352,682	4,674,806
Long term investments	2,586,745
Excess cash	9,403,577	6,997,598	4,330,091
Stockholders' equity	10,307,539	8,577,045	7,005,484
Invested Capital	3,493,462	5,128,454	5,740,411
ROIC	52.96%	27.76%	29.95%
ROCE	21.00%	14.61%	18.03%
EV
Common stock shares outstanding	1,002,004	990,706	994,914
Price	34.58 8.54%	31.86 -15.71%	37.80 34.00%
Market cap	34,649,298 9.78%	31,563,909 -16.07%	37,607,743 32.98%
EV	25,765,946	26,562,451	34,623,640
EBITDA	3,010,228	2,000,614	2,028,123
EV/EBITDA	8.56	13.28	17.07
Interest	58,546	57,741	30,491
Interest/NOPBT	2.12%	3.25%	1.67%